1077 Defining immune selection-driven neoantigen evolution to optimize cancer vaccine targets [PDF]
Mariam Mathew George +9 more
openalex +1 more source
Genetic variants of EcPV2 E6 and E7 in equine genital and oronasal squamous cell carcinoma
Abstract Background Since its discovery in 2008, equine papillomavirus type 2 (EcPV2) has been detected in up to 100% of equine genital and up to 40% of equine oronasal squamous cell carcinomas (SCCs). Preliminary sequence data point to the existence of EcPV2 E6 and E7 oncogene variants compared to the British reference sequence from 2008.
Maya Jenner, Sabine Brandt
wiley +1 more source
Therapeutic Cancer Vaccines in Gastrointestinal Malignancies: Advances, Challenges, and Emerging Strategies. [PDF]
Taing K, Dabirian K, Shreenivas A.
europepmc +1 more source
128 Molecular mimicry in the dark immunopeptidome: viral-homologous non-canonical tumor peptides as targets for off-the-shelf cancer vaccines [PDF]
Angela Mauriello +6 more
openalex +1 more source
Autonomous Nanomedicine: Closing the Biological Validation Gap
Delivery of nanoparticles to tumors has not improved in over fifteen years, and biological testing remains slow and separate from formulation design. This review proposes adding a Biology step to the design cycle, using organ chips and patient‐derived organoids, and assesses the readiness of each required technology.
Yan Jun Lin, Izabella Komperda
wiley +1 more source
Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation. [PDF]
Almarghalani NA +5 more
europepmc +1 more source
728 Enzalutamide impairs CD8 + T cell activation and does not alter the efficacy of AR-targeted vaccine in prostate cancer models [PDF]
Kaitlyn Marie Schneider +4 more
openalex +1 more source
Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu +3 more
wiley +1 more source

